These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8610708)

  • 21. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991.
    Muñoz A; Schrager LK; Bacellar H; Speizer I; Vermund SH; Detels R; Saah AJ; Kingsley LA; Seminara D; Phair JP
    Am J Epidemiol; 1993 Feb; 137(4):423-38. PubMed ID: 8096356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of the efficacy and safety of pre-emptive anti-cytomegalovirus (CMV) therapy in HIV-infected patients with CMV viraemia.
    Mattioni S; Pavie J; Porcher R; Scieux C; Denis B; De Castro N; Simon F; Molina JM
    Int J STD AIDS; 2015 Apr; 26(5):306-12. PubMed ID: 24845948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring of human cytomegalovirus (HCMV)-specific CD4+ T cell frequency by cytokine flow cytometry as a possible indicator for discontinuation of HCMV secondary prophylaxis in HAART-treated AIDS patients.
    Lilleri D; Piccinini G; Genini E; Comolli G; Chiesa A; Tordato F; Sotgiu G; Parisi A; Baldanti F; Revello MG; Gerna G
    J Clin Virol; 2004 Apr; 29(4):297-307. PubMed ID: 15018859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolving trends revealed by autopsies of patients with the acquired immunodeficiency syndrome. 565 autopsies in adults with the acquired immunodeficiency syndrome, Los Angeles, Calif, 1982-1993 [corrected].
    Klatt EC; Nichols L; Noguchi TT
    Arch Pathol Lab Med; 1994 Sep; 118(9):884-90. PubMed ID: 8080357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival in a cohort of human immunodeficiency virus-infected tuberculosis patients in New York City. Implications for the expansion of the AIDS case definition.
    Stoneburner R; Laroche E; Prevots R; Singh T; Blum S; Terry P; Reatrice S; Adler J
    Arch Intern Med; 1992 Oct; 152(10):2033-7. PubMed ID: 1358042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984-1991.
    Jacobson LP; Kirby AJ; Polk S; Phair JP; Besley DR; Saah AJ; Kingsley LA; Schrager LK
    Am J Epidemiol; 1993 Dec; 138(11):952-64. PubMed ID: 7903022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human immunodeficiency virus associated Hodgkin's disease: report of 45 cases from the French Registry of HIV-Associated Tumors.
    Lévy R; Colonna P; Tourani JM; Gastaut JA; Brice P; Raphaël M; Taillan B; Andrieu JM
    Leuk Lymphoma; 1995 Feb; 16(5-6):451-6. PubMed ID: 7540459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand.
    Wannamethee SG; Sirivichayakul S; Phillips AN; Ubolyam S; Ruxrungtham K; Hanvanich M; Phanuphak P
    Int J Epidemiol; 1998 Apr; 27(2):289-95. PubMed ID: 9602412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Causes of death in patients with HIV infection in two Tunisian medical centers].
    Chelli J; Bellazreg F; Aouem A; Hattab Z; Mesmia H; Lasfar NB; Hachfi W; Masmoudi T; Chakroun M; Letaief A
    Pan Afr Med J; 2016; 25():105. PubMed ID: 28292068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cryptosporidiosis among patients infected with human immunodeficiency virus. Factors related to symptomatic infection and survival.
    Colford JM; Tager IB; Hirozawa AM; Lemp GF; Aragon T; Petersen C
    Am J Epidemiol; 1996 Nov; 144(9):807-16. PubMed ID: 8890659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of highly active antiretroviral therapy on the development of CMV disease in HIV positive patients at high risk for CMV disease.
    Verbraak FD; Boom R; Wertheim-van Dillen PM; van den Horn GJ; Kijlstra A; de Smet MD
    Br J Ophthalmol; 1999 Oct; 83(10):1186-9. PubMed ID: 10502584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
    Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G
    Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.
    Durier N; Ananworanich J; Apornpong T; Ubolyam S; Kerr SJ; Mahanontharit A; Ferradini L; Ruxrungtham K; Avihingsanon A
    Clin Infect Dis; 2013 Jul; 57(1):147-55. PubMed ID: 23511301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytomegalovirus, aging, and HIV: a perfect storm.
    Barrett L; Fowke KR; Grant MD
    AIDS Rev; 2012; 14(3):159-67. PubMed ID: 22833059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends and determinants of severe morbidity in HIV-infected patients: the ANRS CO3 Aquitaine Cohort, 2000-2004.
    Bonnet F; Chêne G; Thiébaut R; Dupon M; Lawson-Ayayi S; Pellegrin JL; Dabis F; Morlat P;
    HIV Med; 2007 Nov; 8(8):547-54. PubMed ID: 17944688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accelerated course of human immunodeficiency virus infection after tuberculosis.
    Whalen C; Horsburgh CR; Hom D; Lahart C; Simberkoff M; Ellner J
    Am J Respir Crit Care Med; 1995 Jan; 151(1):129-35. PubMed ID: 7812542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy.
    Deayton JR; Prof Sabin CA; Johnson MA; Emery VC; Wilson P; Griffiths PD
    Lancet; 2004 Jun; 363(9427):2116-21. PubMed ID: 15220032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of opportunistic illnesses incidence in post combination antiretroviral therapy era in an urban cohort from Rio de Janeiro, Brazil.
    Coelho LE; Cardoso SW; Amancio RT; Moreira RI; Ribeiro SR; Coelho AB; Campos DP; Veloso VG; Grinsztejn B; Luz PM
    BMC Infect Dis; 2016 Mar; 16():134. PubMed ID: 27001753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical course of human immunodeficiency virus type 1 associated pulmonary tuberculosis during short-course antituberculosis therapy.
    Schwander SK; Dietrich M; Mugyenyi P; Kityo C; Okwera A; Johnson J; Nsubuga P; Ruesch-Gerdes S; Whalen C
    East Afr Med J; 1997 Sep; 74(9):543-8. PubMed ID: 9487427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.